Cargando…
Neonatal outcomes following new reimbursement limitations on palivizumab in Italy
OBJECTIVE: To evaluate the impact of new reimbursement decisions for palivizumab treatment on respiratory syncytial virus (RSV) hospitalisations and the concomitant number of palivizumab prescriptions for infants aged <2 years. DESIGN: We compared the RSV hospitalisation rates in infants before a...
Autores principales: | Belleudi, Valeria, Trotta, Francesco, Pinnarelli, Luigi, Davoli, Marina, Addis, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287565/ https://www.ncbi.nlm.nih.gov/pubmed/30217858 http://dx.doi.org/10.1136/archdischild-2018-315349 |
Ejemplares similares
-
Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review
por: Belleudi, Valeria, et al.
Publicado: (2021) -
Comparative effectiveness and safety of erythropoiesis-stimulating agents (biosimilars vs originators) in clinical practice: a population-based cohort study in Italy
por: Trotta, Francesco, et al.
Publicado: (2017) -
Drug use and upper gastrointestinal complications in children: a case–control study
por: Bianciotto, Manuela, et al.
Publicado: (2013) -
Drug Prescriptions in the Outpatient Management of COVID-19: Evidence-Based Recommendations Versus Real Practice
por: Belleudi, Valeria, et al.
Publicado: (2022) -
Effect of evidence-based drug therapy on long-term outcomes in patients discharged after myocardial infarction: a nested case–control study in Italy†‡§
por: Kirchmayer, Ursula, et al.
Publicado: (2013)